The BON takeover is an insignifcant event for me. The focus is still squarely and solely on ramping up MAK production within a year or so. Considering 3 directors are common to both companies, just cant see what the big fuss is, whether BON ends up being viable or not. As someone else said it reduces the paperwork and workload of the directors and allows them to prioritise with no conflict. Afterall what would BON holders say if 3 directors said we're going to hold off on any further BON development until we have started MAK production.
Overall not fussed either way and makes no material difference to my investment in MAK.
- Forums
- ASX - By Stock
- AEV
- scrip offer for bonaparte diamond mines
scrip offer for bonaparte diamond mines, page-90
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AEV (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.001(20.0%) |
Mkt cap ! $14.09M |
Open | High | Low | Value | Volume |
0.5¢ | 0.6¢ | 0.5¢ | $18.72K | 3.744M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 224231 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 10091524 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 224231 | 0.005 |
15 | 15886980 | 0.004 |
11 | 6740003 | 0.003 |
4 | 3175000 | 0.002 |
7 | 10749950 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 10091524 | 13 |
0.007 | 3887938 | 6 |
0.008 | 4852760 | 7 |
0.009 | 351000 | 1 |
0.010 | 1151252 | 3 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online